Tectonic Therapeutic (TECX) Cash from Operations (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Cash from Operations of 18413000.0 for Q1 2026, down 40.74% year-over-year from 31071492.2 in Q1 2025, and down 27.33% quarter-over-quarter from 14461000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Cash from Operations (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Cash from Operations for 10 consecutive years, with 18413000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 40.74% year-over-year to 18413000.0; the TTM figure through Mar 2026 stood at 65408000.0 (down 4.0% YoY), while the FY2025 annual figure was 60078000.0, down 1.69% from the prior year.
- Cash from Operations declined to 18413000.0 in Q1 2026 per TECX's latest filing, from 14461000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 259000.0 in Q2 2023 and bottomed at 29106000.0 in Q2 2022.
- Historically, Cash from Operations has averaged 16203529.41 across 5 years, with a median of 16415000.0 in 2022.
- Annual changes were most pronounced in 2023 — Cash from Operations jumped 99.11% — and 2024, when it sank 5066.8%.
- Tectonic Therapeutic's Cash from Operations stood at 23673000.0 in 2022, then soared by 50.76% to 11657000.0 in 2023, then sank by 44.3% to 16821000.0 in 2024, then climbed by 14.03% to 14461000.0 in 2025, then dropped by 27.33% to 18413000.0 in 2026.
- Business Quant data shows TECX's Cash from Operations at 18413000.0 in Q1 2026, 14461000.0 in Q4 2025, and 17815000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | -21.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.45 Mn |
| Jun 30, 2026 | -21.45 Mn |
| Mar 31, 2026 | -18.41 Mn |
| Mar 31, 2026 | -18.41 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Sep 30, 2025 | -17.82 Mn |
| Sep 30, 2025 | -17.82 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Mar 31, 2025 | -13.08 Mn |
| Mar 31, 2025 | -13.08 Mn |
| Dec 31, 2024 | -16.82 Mn |
| Dec 31, 2024 | -16.82 Mn |
| Sep 30, 2024 | -19.60 Mn |
| Sep 30, 2024 | -19.60 Mn |
| Jun 30, 2024 | -13.38 Mn |
| Jun 30, 2024 | -13.38 Mn |
| Mar 31, 2024 | -9.27 Mn |
| Mar 31, 2024 | -9.27 Mn |